4D Molecular Therapeutics Inc (FDMT)
R&D to Revenue
1805.92%
Quarterly · Period ending:
FDMT R&D to Revenue
Latest reported1805.92%period ending
Latest reported1805.92%period ending
FDMT Quarterly R&D/Revenue (161.93% → 1805.92%)
Latest values, visible window
High-resolution chart · PNG
FDMT r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 1,805.9244% | |
| 2,132.5894% | |
| 67.7024% | |
| 54,931.1111% | |
| 319,673.3333% | |
| 290,707.1429% | |
| 4,308,500% | |
| 1,282,800% | |
| 637,200% | |
| 99,535.7143% | |
| -136,989.4737% | |
| 124.0645% | |
| 9,867.7824% | |
| 7,520.8054% | |
| 1,724.1379% | |
| 3,788% | |
| 12,606.1728% | |
| 1,589.9098% | |
| 19,052.1739% | |
| 1,159.59% | |
| 104.4102% | |
| 638.45% | |
| -1,290.174% | |
| 155.7068% | |
| 432.7002% | |
| 372.2207% | |
| 608.8177% | |
| 1,735.9259% | |
| 384.6241% | |
| 384.6241% | |
| 112.0627% | |
| 112.0627% | |
| 161.9254% | |
| 161.9254% |